Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 7.10x is 377% above its 5-year average of -2.56x, around the middle of its 5-year range (-4961.00x–4141.00x).
64.35% below its 12-month average of 19.92x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 2.71x.
INTEREST COVERAGE RATIO
7.10x
INTEREST COVERAGE RATIO AVG TTM
19.92x
INTEREST COVERAGE RATIO AVG 3Y
-18.69x
INTEREST COVERAGE RATIO AVG 5Y
-2.56x
INTEREST COVERAGE RATIO AVG 10Y
-7.75x
INTEREST COVERAGE RATIO AVG 15Y
-1091.66x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-64.35%
CURRENT VS 3Y AVG
+137.98%
CURRENT VS 5Y AVG
+376.89%
CURRENT VS 10Y AVG
+191.61%
CURRENT VS 15Y AVG
+100.65%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+211.37%
vs the sector median at left
Vericel Corporation
Market Cap
$2.08B
Interest Coverage Ratio
7.10x
TTM Avg
19.92x
3Y Avg
-18.69x
5Y Avg
-2.56x
Market Cap
$2.08B
Interest Coverage Ratio
-41.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.07B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.07B
Interest Coverage Ratio
-73.44x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.11B
Interest Coverage Ratio
14.46x
TTM Avg
13.87x
3Y Avg
10.91x
5Y Avg
11.49x
Market Cap
$2.04B
Interest Coverage Ratio
4.32x
TTM Avg
4.32x
3Y Avg
4.32x
5Y Avg
4.32x
Market Cap
$2.04B
Interest Coverage Ratio
N/A
TTM Avg
166.84x
3Y Avg
166.84x
5Y Avg
166.84x
Market Cap
$2.03B
Interest Coverage Ratio
-0.33x
TTM Avg
467.98x
3Y Avg
502.49x
5Y Avg
502.49x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vericel Corporation (VCEL) | $2.08B | 7.10x | 19.92x | -18.69x | -2.56x |
| Vera Therapeutics, Inc. (VERA)vs › | $2.08B | -41.89x | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.07B | 0.52x | 0.48x | 0.48x | 0.48x |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.07B | N/A | N/A | N/A | N/A |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.07B | -73.44x | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 14.46x | 13.87x | 10.91x | 11.49x |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 4.32x | 4.32x | 4.32x | 4.32x |
| Progyny, Inc. (PGNY)vs › | $2.04B | N/A | 166.84x | 166.84x | 166.84x |
| Fortrea Holdings Inc. (FTRE)vs › | $2.03B | -0.33x | 467.98x | 502.49x | 502.49x |
| UroGen Pharma Ltd. (URGN)vs › | $2.04B | -3.69x | N/A | N/A | N/A |
Interest Coverage
7.1x
Debt/Equity
0.25
Current Ratio
5.04
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.71x |
| 2026-03-31 | -50.40x |
| 2025-12-31 | 138.36x |
| 2025-09-30 | 21.84x |
| 2025-06-30 | -12.92x |
| 2025-03-31 | -83.61x |
| 2024-12-31 | 119.99x |
| 2024-09-30 | -16.01x |
| 2024-06-30 | -39.42x |
| 2024-03-31 | -35.71x |
| 2023-12-31 | 81.61x |
| 2023-09-30 | -33.71x |
| 2023-06-30 | -40.01x |
| 2023-03-31 | -56.39x |
| 2022-12-31 | 27.29x |
| 2022-09-30 | -64.65x |
| 2022-06-30 | -454.10x |
| 2022-03-31 | -404.06x |
| 2021-12-31 | 4141.00x |
| 2021-09-30 | -4961.00x |
| 2021-06-30 | -3729.00x |
| 2021-03-31 | -3305.00x |
| 2020-12-31 | 12289.00x |
| 2020-09-30 | 1758.50x |
| 2020-06-30 | -8358.00x |
| 2020-03-31 | -2538.00x |
| 2019-12-31 | 4605.00x |
| 2019-09-30 | 1548.50x |
| 2019-06-30 | -10100.00x |
| 2019-03-31 | -1679.00x |
| 2018-12-31 | 15.29x |
| 2018-09-30 | -2.90x |
| 2018-06-30 | -9.48x |
| 2018-03-31 | -10.00x |
| 2017-12-31 | 5.20x |
| 2017-09-30 | -12.72x |
| 2017-06-30 | -8.43x |
| 2017-03-31 | -36.73x |
| 2016-12-31 | -26.53x |
| 2016-09-30 | -74.19x |
| 2016-06-30 | -1661.33x |
| 2016-03-31 | -664.00x |
| 2015-12-31 | -1652.33x |
| 2015-09-30 | -2438.50x |
| 2015-06-30 | -1132.50x |
| 2015-03-31 | -2286.00x |
| 2014-12-31 | -1173.00x |
| 2014-09-30 | -8022.00x |
| 2014-06-30 | -4261.00x |
| 2014-03-31 | -2322.50x |
| 2013-12-31 | -2462.00x |
| 2013-09-30 | -1213.67x |
| 2013-06-30 | -1744.67x |
| 2013-03-31 | -2388.33x |
| 2012-12-31 | -3808.50x |
| 2012-09-30 | -2071.25x |
| 2012-06-30 | -3100.00x |
| 2012-03-31 | -2852.67x |
| 2011-12-31 | -2611.33x |
| 2011-09-30 | -2479.67x |
| 2011-06-30 | -3753.50x |
| 2011-03-31 | -3130.00x |
| 2010-09-30 | -1170.60x |
| 2010-06-30 | -734.29x |
| 2010-03-31 | -473.67x |
| 2009-12-31 | -416.82x |
| 2009-09-30 | -293.54x |
| 2009-06-30 | -265.73x |
| 2009-03-31 | -236.00x |
| 2008-12-31 | -207.60x |
